Company Accounts and Tax Online 14892017 Board of Directors 1.6.24 31.5.25 31.5.25 false iso4217:GBP xbrli:pure 14892017 2023-05-24 2024-05-31 14892017 2025-05-31 14892017 2024-06-01 2025-05-31 14892017 2024-05-31 14892017 countries:EnglandWales 2024-06-01 2025-05-31 14892017 curr:PoundSterling 2024-06-01 2025-05-31 14892017 uk-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 14892017 uk-bus:Micro-entities 2024-06-01 2025-05-31 14892017 uk-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 14892017 uk-bus:FullAccounts 2024-06-01 2025-05-31 14892017 uk-bus:RegisteredOffice 2024-06-01 2025-05-31 14892017 uk-bus:Director1 2024-06-01 2025-05-31 14892017 uk-bus:Director1 2024-06-01 14892017 uk-bus:Director1 2025-05-31 14892017 core:AfterOneYear 2025-05-31 14892017 core:AfterOneYear 2024-05-31 14892017 core:WithinOneYear 2025-05-31 14892017 core:WithinOneYear 2024-05-31 14892017 core:WithinOneYear 2024-06-01 2025-05-31 14892017 core:AfterOneYear 2025-05-31 14892017 core:AfterOneYear 2024-05-31 14892017 core:AfterOneYear 2024-06-01 2025-05-31 14892017 core:ShareCapital 2025-05-31 14892017 core:ShareCapital 2024-05-31 14892017 core:RevaluationReserve 2025-05-31 14892017 core:RevaluationReserve 2024-05-31 14892017 core:RetainedEarningsAccumulatedLosses 2025-05-31 14892017 core:RetainedEarningsAccumulatedLosses 2024-05-31 14892017 1 2024-06-01 2025-05-31

# TANYA HEALTHCARE LIMITED

## Company Registration Number:
14892017 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 May 2025

## Period of accounts

## Start date: 01 June 2024

## End date: 31 May 2025

# TANYA HEALTHCARE LIMITED

## Contents of the Financial Statements

for the Period Ended 31 May 2025

Company Information - 3 |
Report of the Directors - 4 |
Balance sheet - 5 |
Footnotes to the Balance Sheet - 7 |

# TANYA HEALTHCARE LIMITED

## Company Information

for the Period Ended 31 May 2025

Director: |  | Antoinette Salonga
Registered office: |  | 57a The Burroughs London England NW4 4AX
Company Registration Number: |  | 14892017 (England and Wales)

# TANYA HEALTHCARE LIMITED

## Directors' Report Period Ended 31 May 2025

The directors present their report with the financial statements of the company for the period ended 31 May 2025

Principal Activities

The principal activity of the business continues to be that of providing healthcare services.

Directors

The directors shown below have held office during the whole of the period from 01 June 2024 to 31 May 2025
Antoinette Salonga

This report was approved by the board of directors on 13 February 2026
And Signed On Behalf Of The Board By:

Name: Antoinette Salonga
Status: Director

# TANYA HEALTHCARE LIMITED

## Balance sheet

As at 31 May 2025

| 2025 £ | 2024 £
--- | --- | ---
Current assets: | 1,107 | 2,014
Creditors: amounts falling due within one year: |  | ( 573 )
Net current assets (liabilities): | 1,107 | 1,441
Total assets less current liabilities: | 1,107 | 1,441
Total net assets (liabilities): | 1,107 | 1,441
Capital and reserves: | 1,107 | 1,441

# TANYA HEALTHCARE LIMITED

## Balance sheet continued

For the year ending 31 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 13 February 2026
And Signed On Behalf Of The Board By:

Name: Antoinette Salonga
Status: Director

The notes form part of these financial statements

# TANYA HEALTHCARE LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 May 2025

- ## 1. Employee Information

  Average number of employees: 0

# TANYA HEALTHCARE LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 May 2025

- ## 2. Off balance sheet disclosure

  No